We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 315

Standard-Essential Patents and Pooling - March 2016 - April 2016 Developments
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Canada, European Union, India, United Kingdom, USA
  • April 29 2016

April 13, 2016: Microsoft alleged unlawful monopolization under Section 2 of the Sherman Act in relation to InterDigital's licensing of patents


International Law Bulletin - Vol. 21, No. 1
  • Nelson Mullins Riley & Scarborough LLP
  • Canada, China, Cuba, India, Sri Lanka, USA
  • March 8 2016

Imports of amorphous silica fabric from China, a heat resistance material, will be investigated for dumping and unfair subsidies (33 ITR 267


Import Ban Quashed, and Health Canada Ordered to Retract Its Statements re Same
  • Borden Ladner Gervais LLP
  • Canada
  • January 13 2016

Apotex et al brought a judicial review of the Minister of Health's (the Minister) decision to impose an import ban on products from two of Apotex'


IP Update - 4th Quarter 2015
  • Marks & Clerk
  • Australia, Canada, China, European Union, Malaysia, Singapore, United Kingdom
  • December 16 2015

The unitary Community Trade Mark (CTM) was introduced in 1996. Since then, there have been no major changes to the system. However, the IP landscape


TPP: new rights for pharmaceutical patent holders
  • Gowling WLG
  • Canada
  • December 9 2015

On November 5 2015 the Canadian government released the official consolidated text of the Trans-Pacific Partnership (TPP). This follows the technical


The TPP new rights for pharmaceutical patent holders in Canada
  • Gowling WLG
  • Canada
  • November 13 2015

The Canadian Government released the official consolidated text of the Trans-Pacific Partnership (TPP) agreement on Nov., 5, 2015. This follows the


The Trans-Pacific partnership: changes for patents and pharmaceuticals?
  • Gowling WLG
  • Asia-Pacific, Canada
  • October 8 2015

Changes may be on the horizon for Canada’s legal and regulatory regime for patents and pharmaceuticals. Included in the Trans-Pacific Partnership


Canadian patent term extension the treaty text is released
  • Bereskin & Parr LLP
  • Canada
  • December 2 2014

Canada and Europe announced in October 2013, an agreement in principle on a Comprehensive Economic and Trade Agreement (CETA). Its most significant


Patent term restoration for Canadian pharmaceutical patents
  • Norton Rose Fulbright LLP
  • Canada, European Union
  • November 28 2014

The signature of the free-trade agreement texts between Canada and the European Union provided additional details on the provisions relating to the


Canada-EU Comprehensive Economic and Trade Agreement negotiation completed: additional protection for innovative pharmaceutical products
  • Fasken Martineau DuMoulin LLP
  • Canada, European Union
  • October 1 2014

On September 26, 2014, Canada and the EU announced completion of negotiations on the Canada-EU Comprehensive Economic and Trade Agreement (CETA